These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6458716)

  • 1. [Observation on urinary fibrinolytic activity in various renal disease (author's transl)].
    Shibata M; Yamamoto A; Kishi T; Shimizu K; Kobayashi K; Sakai H; Ohtaka M
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):349-57. PubMed ID: 6458716
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of bromelain on fibrinolytic and antifibrinolytic enzyme systems (author's transl)].
    Miyatani K; Takahata J; Fukui I
    Rinsho Byori; 1975 Mar; 23(3):201-4. PubMed ID: 125811
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of elastase on fibrinolytic and antifibrinolytic enzyme systems (author's transl)].
    Miyatani K; Takahata J; Fukui I
    Rinsho Byori; 1975 Mar; 23(3):205-8. PubMed ID: 125812
    [No Abstract]   [Full Text] [Related]  

  • 4. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assay of fibrinolytic factors with plasminogen-free bovine fibrin-agar-plate and its clinical application. I. Some properties of plate and features for estimation of fibrinolytic factors (author's transl)].
    Abe T; Kazama M; Satoh A; Suzuki J; Yamamoto S
    Rinsho Ketsueki; 1975 Oct; 16(10):946-52. PubMed ID: 128644
    [No Abstract]   [Full Text] [Related]  

  • 6. [A clinical study on urinary kallikrein in patients with renal diseases (author's transl)].
    Numahata H
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):203-17. PubMed ID: 470231
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the standardization of fibrinolysis tests. II. Clinical significance of determination of fibrinolytic factors and its interpretation (author's transl)].
    Egawa H; Hashimoto S; Suzuki K
    Rinsho Byori; 1979 Mar; 27(3):250-6. PubMed ID: 155750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Releasing of plasminogen-activator from the kidney to the blood (author's transl)].
    Nakata A; Hagita M; Okamoto U
    Nihon Seirigaku Zasshi; 1978 Nov; 40(11):419-26. PubMed ID: 155161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
    Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tissue fibrinolytic activity in DNCB contact dermatitis (author's transl)].
    Ogawa K; Harada S; Nakabayashi M; Satoh K
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):935-8. PubMed ID: 153419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
    Shibata M; Shimizu K; Kishi T; Kobayashi K; Sakai H; Sugiyama H; Oguri M
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1197-207. PubMed ID: 6450847
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic activity of proactivator and activator in human urine.
    Kamada T
    Nihon Hoigaku Zasshi; 1967 Nov; 21(6):541-51. PubMed ID: 4233846
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical investigations on urinary fibrinolysis in bladder carcinoma (author's transl)].
    Ueda S; Hirayama H; Arita M; Ikegami K
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1241-6. PubMed ID: 732059
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H; Shibata M
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of the enzyme activity of the fibrinolytic system using fibrinogen conjugated with peroxidase].
    Liaginskiĭ AV; AfanasenkoGA ; Gudkova EV
    Lab Delo; 1991; (11):27-31. PubMed ID: 1722843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytic activity of the renal glomerulus. Preliminary results of a histochemical study of plasminogen activity in 44 renal biopsies].
    Arrigo G; Baroni M; Benuzzi S; Bellini A; Chiesa I; Colasanti G; D'Amico G
    Minerva Nefrol; 1979; 26(4):459-62. PubMed ID: 161611
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estimation of plasminogen tissue activator (author's transl)].
    Kohga S; Kanamori T; Kawai N
    Rinsho Byori; 1976 Apr; 24(4):321-4. PubMed ID: 945387
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on human urinary enzymes and inhibitors. Concentration method and characterization.
    Sumi H; Toki N; Takada Y; Takada A
    J Biochem; 1978 Jan; 83(1):141-7. PubMed ID: 146706
    [No Abstract]   [Full Text] [Related]  

  • 19. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on unexplained renal hematuria. 1. Clinical studies of peripheral blood examination and fibrinolytic enzyme systems in patients with various types of renal hematuria (author's transl)].
    Hayashi M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):42-59. PubMed ID: 7024604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.